Literature DB >> 21346940

Investigating drug classes in biomedical terminologies from the perspective of clinical decision support.

Olivier Bodenreider1, Dina Demner Fushman.   

Abstract

OBJECTIVES: To assess whether 1) the necessary drug classes and 2) the necessary drug-class membership relations are represented in biomedical terminologies in order to support clinical decision regarding drug-drug interactions.
METHODS: In order to investigate drug classes and drug-class membership in clinical terminologies, we start by establishing a reference list of these entities. Then, we map drugs and classes to the UMLS, where we investigate their relations.
RESULTS: 186 (83%) of the 223 names for drug classes mapped to the UMLS. The single best source is SNOMED CT with 75%. 140 (89%) of the 157 drug-membership relations were found in the UMLS.
CONCLUSIONS: One important category of drug classes missing from all clinical terminologies is related to drug metabolism by the Cytochrome P450 enzyme family.

Mesh:

Year:  2010        PMID: 21346940      PMCID: PMC3041355     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  6 in total

1.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

2.  What's more dangerous, your aspirin or your car? Thinking rationally about drug risks (and benefits).

Authors:  Joshua T Cohen; Peter J Neumann
Journal:  Health Aff (Millwood)       Date:  2007 May-Jun       Impact factor: 6.301

Review 3.  Does computerized provider order entry reduce prescribing errors for hospital inpatients? A systematic review.

Authors:  Margaret H Reckmann; Johanna I Westbrook; Yvonne Koh; Connie Lo; Richard O Day
Journal:  J Am Med Inform Assoc       Date:  2009-06-30       Impact factor: 4.497

4.  Preventing drug interactions by online prescription screening in community pharmacies and medical practices.

Authors:  H Halkin; I Katzir; I Kurman; J Jan; B B Malkin
Journal:  Clin Pharmacol Ther       Date:  2001-04       Impact factor: 6.875

Review 5.  Medication-related clinical decision support in computerized provider order entry systems: a review.

Authors:  Gilad J Kuperman; Anne Bobb; Thomas H Payne; Anthony J Avery; Tejal K Gandhi; Gerard Burns; David C Classen; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2006-10-26       Impact factor: 4.497

6.  Tiering drug-drug interaction alerts by severity increases compliance rates.

Authors:  Marilyn D Paterno; Saverio M Maviglia; Paul N Gorman; Diane L Seger; Eileen Yoshida; Andrew C Seger; David W Bates; Tejal K Gandhi
Journal:  J Am Med Inform Assoc       Date:  2008-10-24       Impact factor: 4.497

  6 in total
  3 in total

1.  High-priority drug-drug interactions for use in electronic health records.

Authors:  Shobha Phansalkar; Amrita A Desai; Douglas Bell; Eileen Yoshida; John Doole; Melissa Czochanski; Blackford Middleton; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2012-04-26       Impact factor: 4.497

2.  Interoperability of Medication Classification Systems: Lessons Learned Mapping Established Pharmacologic Classes (EPCs) to SNOMED CT.

Authors:  Scott D Nelson; Jaqui Parker; Robert Lario; Rainer Winnenburg; Mark S Erlbaum; Michael J Lincoln; Olivier Bodenreider
Journal:  Stud Health Technol Inform       Date:  2017

3.  A framework for assessing the consistency of drug classes across sources.

Authors:  Rainer Winnenburg; Olivier Bodenreider
Journal:  J Biomed Semantics       Date:  2014-07-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.